Number of Shares
9.54 Mil
Current Holdings Value*
$13.46 Mil
% of Portfolio
4.42%
Total Estimate Gain
$-2.08 Mil
% of Total Estimate Gain
-6.60%

Prosight Management, LP's ADC Therapeutics SA Holding Summary

As of 2025-03-31, Prosight Management, LP held 9.54 Mil shares of ADC Therapeutics SA(ADCT), totaling $13.46 Mil. This investment constitutes 4.42% of their stock portfolio, and Prosight Management, LP now holds 9.62% of the outstanding ADC Therapeutics SA(ADCT) stock.

The initial trade took place in 2022Q3. And since then Prosight Management, LP has made 9 purchases of ADCT, at an average price of $3.20, for a total of 9.85 Mil shares. In addition, there have been 2 sales at an average price of $1.84 for 303,096.00 shares. Based on historical transaction data and ADCT's current price of $3.03, Prosight Management, LP's estimated gain on his ADCT holdings is $-2.08 Mil, reflecting a -6.60% gain to date.

Prosight Management, LP ADCT ($3.03) Holding Chart

Prosight Management, LP ADCT ($3.03) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1